Fig. 7From: Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validationHF reduces the expression of IL-17 C, p-NF-κB, and MMP9 in the IL-17 signaling pathway of activated macrophages. (A, B) IL-17 C immunofluorescence expression in macrophages, along with the corresponding fluorescence intensity data (n = 3 per group). (C, D) p-NF-κB immunofluorescence expression in macrophages, along with the fluorescence intensity data (n = 3 per group). (E, F) MMP9 immunofluorescence expression in macrophages, along with the fluorescence intensity data (n = 3 per group). The data are represented as means ± SD; * p < 0.05, ** p < 0.01, *** p < 0.001Back to article page